Helping clinicians and scientists to share research and new approaches to prevent, diagnose, treat, and one day cure HIV/AIDS.
Learn More
You are here: Home Directory Local clinical studies

Local clinical studies

UC San Diego AIDS Research Institute affiliates that specialize in clinical HIV research and clinical trials

The UCSD AntiViral Research Center (AVRC) is a clinical trials unit established in 1986 to conduct patient-oriented research and educational programs on HIV and other chronic infections. AVRC studies have pioneered the development of treatments that continue to change the course of the HIV epidemic. Our top research priorities include developing new HIV medications; combating drug resistance;  understanding metabolic complications of therapy; testing approaches to simplifying therapy; identifying and treating newly infected patients; treating patients co-infected with HIV and hepatitis C; evaluating HIV vaccines and immune therapy; testing infants and children for HIV; and caring for HIV-infected infants, children, adolescents, and mothers. Many ACTG and PACTG studies are conducted at the AVRC.

The HIV Neurobehavioral Research Program (HNRP) conducts research that brings together a variety of scientific disciplines and methods to further our understanding of how the brain and nervous system function and how they are affected by HIV disease. Studies at the HNRP are numerous and varied, covering topics as diverse as behavioral interventions to improve antiretroviral adherence, HIV and amphetamine users; sources and neurocognitive correlates of HIV RNA in cerebrospinal fluid, clinical trial of memantine for AIDS Dementia Complex (ADC), computerized (CANTAB) assessment of HIV-associated neurocognitive disorders, treatments for AIDS retinopathy, development of Spanish-language neuropsychological test norms, effects of methamphetamine and HIV on brain function, and neuropathological investigations of HIV infection.

The UCSD Translational Methamphetamine AIDS Research Center (TMARC) is the first center in the United States to study the combined effects of methamphetamine use and HIV infection in the brain. The Center's ultimate goal is to become a national resource for translational multidisciplinary research and training in the neurological effects of HIV and substance abuse.